Quick links

Secure login

Secure file transfer protocol

Register or renew user


Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944


Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

Author: Viviana Sanchez-Gomez

As the respiratory syncytial virus (RSV) season draws to a close on March 31, 2025, we want to remind all healthcare providers of essential considerations regarding administering the RSV immunization, nirsevimab (Beyfortus).   End of RSV season: Continue to administer doses of nirsevimab to eligible children through March 31,...

Educate your patients about Influenza! According to the Centers for Disease Control and Prevention, influenza levels nationwide are at their highest since the peak of the 2009 swine flu pandemic. Nationally, CDC reports 98 pediatric deaths this season. This season is now classified as a high severity season for...

Our Spring PIC conference is coming up. We hope to see you there.  Questions? Interested in being a panelist? Email angel.brice@phila.gov. ...

PhilaVax Closed to VFC & VFAAR Orders from 3/26 through 4/1 PhilaVax will be temporarily closed to new orders from 12 p.m. on Wednesday, March 26, 2025, until Wednesday, April 2, 2025, while the vaccine prices are updated for 2025. Any orders entered into PhilaVax IIS during this time will be...

MMR vaccination is essential for healthcare professionals, international travelers, and other specific groups. Measles continues to circulate in the United States, with a large outbreak currently growing in Texas. Adults should be up to date on MMR vaccinations with either 1 or 2 doses (depending on risk factors);...

Update by March 28, 2025 Digital Data Loggers (DDLs) provided by the Philadelphia Department of Public Health (PDPH) use LogTag software to download temperature data. LogTag version 2 is no longer supported and may cause data reporting errors. Therefore, all providers who use PDPH-provided DDLs must update...

Recommend HPV Vaccine Using the Guidance Below The HPV vaccine is approved for ages 9 years through 45 years for all genders. The American Cancer Society and American Academy of Pediatrics (AAP) recommend vaccination starting at age 9. Early vaccination at ages 9-10 has several benefits, including...

Complete the survey! The Philadelphia Immunization Program thanks you for participating in the COVID-19 Bridge Access Program. You played a crucial role in ensuring underinsured and uninsured adults in Philadelphia could access COVID-19 vaccines. Now that the Bridge Access Program has ended, we're asking providers who were enrolled to complete a Provider Satisfaction Survey. Thank you...

Re-enrollment Opens February 1, 2025 The Philadelphia Vaccines for Children (VFC) and Vaccines for Adults at Risk (VFAAR) annual re-enrollment period will take place from February 1 to February 28, 2025. The enrollment will be done electronically through PhilaVax. Prepare for Re-enrollment Complete these steps now!  Update Clinic Tools Review...

Deliveries will resume December 30, 2024 Due to the upcoming Christmas holiday, mpox vaccine deliveries will be on hold during the week of December 23, 2024. Remember to submit your temperatures to tempcheck@phila.gov and complete a reconciliation of the vaccine on hand for your order to...